4/25
08:45 am
bhc
Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research [Yahoo! Finance]
Low
Report
Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research [Yahoo! Finance]
4/23
11:52 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have a "sector perform" rating on the stock.
Low
Report
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have a "sector perform" rating on the stock.
4/17
10:08 pm
bhc
Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033 [Yahoo! Finance]
Low
Report
Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033 [Yahoo! Finance]
4/16
04:19 pm
bhc
Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards [Yahoo! Finance]
Low
Report
Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards [Yahoo! Finance]
4/16
04:00 pm
bhc
Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards
Low
Report
Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards
4/16
09:38 am
bhc
John Paulson's ‘Money Machine' Is Still in the Red After 2023's Big Gains [Yahoo! Finance]
Low
Report
John Paulson's ‘Money Machine' Is Still in the Red After 2023's Big Gains [Yahoo! Finance]
4/12
11:09 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
Bausch Health Companies Inc. (NYSE: BHC) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
4/11
04:22 pm
bhc
Bausch Health to Announce First-Quarter 2024 Results on May 2
Low
Report
Bausch Health to Announce First-Quarter 2024 Results on May 2
4/11
01:03 pm
bhc
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Low
Report
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
4/11
11:18 am
bhc
Canadian Investment Regulatory Organization Trade Resumption - BHC
Medium
Report
Canadian Investment Regulatory Organization Trade Resumption - BHC
4/11
11:07 am
bhc
Bausch Health pares gain after appeals court affirms ruling in Norwich patent case [Seeking Alpha]
Low
Report
Bausch Health pares gain after appeals court affirms ruling in Norwich patent case [Seeking Alpha]
4/11
11:04 am
bhc
Canadian Investment Regulatory Organization Trading Halt - BHC
Medium
Report
Canadian Investment Regulatory Organization Trading Halt - BHC
4/11
10:09 am
bhc
AscellaHealth Expands Executive Team: Industry Veterans Lead Development and Implementation of End-to-End Payer Solutions and Pharmacy Operations to Control Specialty Spend [Yahoo! Finance]
Low
Report
AscellaHealth Expands Executive Team: Industry Veterans Lead Development and Implementation of End-to-End Payer Solutions and Pharmacy Operations to Control Specialty Spend [Yahoo! Finance]
4/11
08:14 am
bhc
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan [Yahoo! Finance]
Low
Report
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan [Yahoo! Finance]
4/11
08:00 am
bhc
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
Low
Report
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
4/10
08:43 am
bhc
Optometry Equipment Market is Expected to Reach $6.1 billion | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Optometry Equipment Market is Expected to Reach $6.1 billion | MarketsandMarkets™ [Yahoo! Finance]
4/10
04:03 am
bhc
Global Myopia Treatment Market to Reach $19.57 Billion by 2030: Ortho-K Lenses and Atropine Eye Drops Enhance Myopia Management, Broaden Patient Access [Yahoo! Finance]
Medium
Report
Global Myopia Treatment Market to Reach $19.57 Billion by 2030: Ortho-K Lenses and Atropine Eye Drops Enhance Myopia Management, Broaden Patient Access [Yahoo! Finance]
4/8
05:42 pm
bhc
CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision [Yahoo! Finance]
Medium
Report
CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision [Yahoo! Finance]
4/8
03:36 pm
bhc
Bausch Health drops after suing Amneal Pharma over Xifaxan generic [Seeking Alpha]
Low
Report
Bausch Health drops after suing Amneal Pharma over Xifaxan generic [Seeking Alpha]
4/8
02:43 pm
bhc
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan [Yahoo! Finance]
Low
Report
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan [Yahoo! Finance]
4/6
09:28 am
bhc
Bausch Health sues Amneal Pharma over Xifaxan generic [Seeking Alpha]
Medium
Report
Bausch Health sues Amneal Pharma over Xifaxan generic [Seeking Alpha]
4/5
06:15 pm
bhc
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
Medium
Report
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
4/5
08:03 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) had its price target raised by analysts at Royal Bank of Canada from $9.00 to $12.00. They now have a "sector perform" rating on the stock.
Medium
Report
Bausch Health Companies Inc. (NYSE: BHC) had its price target raised by analysts at Royal Bank of Canada from $9.00 to $12.00. They now have a "sector perform" rating on the stock.
4/3
12:06 pm
bhc
Canadian Investment Regulatory Organization Trade Resumption - BHC
Low
Report
Canadian Investment Regulatory Organization Trade Resumption - BHC
4/3
12:02 pm
bhc
Canadian Investment Regulatory Organization Trading Halt - BHC
Low
Report
Canadian Investment Regulatory Organization Trading Halt - BHC